Generate a tailored SOP for Dr. Priyanka Hastak. Improve your application with a focused, well-structured draft.
Priyanka Hastak is a postdoctoral scientist at the Kirby Institute specializing in human translational immunology. Her research focuses on acute lung injuries, pneumonia, and sepsis, particularly immune responses in vaccinated and immunocompromised individuals. Dr. Hastak aims to bridge molecular insights with clinical applications to improve outcomes for critically ill patients. She earned her PhD from the University of Technology Sydney, where she conducted groundbreaking research in genomic surveillance of antimicrobial-resistant pathogens in patients with bloodstream infections and sepsis. As part of the AusGem initiative, she utilized long-read sequencing and advanced bioinformatics to elucidate the resistance and virulence mechanisms of emerging multidrug-resistant E. coli clones of global significance. Currently, Dr. Hastak is part of the Immunovirology Pathogenesis Program at the Kirby Institute, contributing to several studies that employ multi-omics approaches. Her expertise spans molecular biology, genomics, transcriptomics, lung microbiome analysis, and cytokine profiling. Dr. Hastak's work aims to understand the immune landscape of ICU patients with acute lung injuries to inform clinicians about repurposed novel immunotherapies, ultimately helping to optimize treatment strategies for these patients.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.